EUVIMEDEUVIMED entdecken
Open Access

State-of-the-Art: Hypo-responsiveness to Oral Antiplatelet Therapy in Patients with Type 2 Diabetes Mellitus

Dharam J Kumbhani, Steven P Marso, Carlos A Alvarez, Darren K McGuire

Current Cardiovascular Risk Reports · 2015-02 · 9 (2)

DOI: 10.1007/s12170-014-0430-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Cardiovascular Risk Reports, online erschienen am 29.01.2015. Verfasst von Dharam J Kumbhani und 3 weiteren Autor:innen. Beteiligte Einrichtung: UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9047, /. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus is a global pandemic, associated with a high burden of cardiovascular disease. There are multiple platelet derangements in patients with diabetes, and antiplatelet drugs remain the first-line agents for secondary prevention as well as for high-risk primary prevention among patients with diabetes. This review provides a summary of oral antiplatelet drug hypo-responsiveness in patients with diabetes, specifically aspirin and Clopidogrel resistance. Topics discussed include antiplatelet testing, definitions used to define hypo-response and resistance, its prevalence, association with clinical outcomes and strategies to mitigate resistance. The role of prasugrel and ticagrelor, as well as investigational agents, is also discussed.

Schlagwörter

Stichwörter der Autor:innen

Clopidogrel resistanceantiplateletantiplatelet resistanceaspirin resistancediabetes mellitushigh on-treatment platelet reactivityplatelets

Autor:innen und Institutionen

  • UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9047, /
  • UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-, /
  • Texas Tech University Health Sciences Center, 5920 Forest Park Road, Dallas, TX 75235, /
  • UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-8830, /

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Kumbhani, D. J., Marso, S. P., Alvarez, C. A., & McGuire, D. K. (2015). State-of-the-Art: Hypo-responsiveness to Oral Antiplatelet Therapy in Patients with Type 2 Diabetes Mellitus. Current Cardiovascular Risk Reports, 9(2). https://doi.org/10.1007/s12170-014-0430-5

Vancouver

Kumbhani DJ, Marso SP, Alvarez CA, McGuire DK. State-of-the-Art: Hypo-responsiveness to Oral Antiplatelet Therapy in Patients with Type 2 Diabetes Mellitus. Current Cardiovascular Risk Reports. 2015;9(2). doi:10.1007/s12170-014-0430-5

BibTeX
@article{Kumbhani2015,
  author = {Kumbhani, Dharam J and Marso, Steven P and Alvarez, Carlos A and McGuire, Darren K},
  title = {State-of-the-Art: Hypo-responsiveness to Oral Antiplatelet Therapy in Patients with Type 2 Diabetes Mellitus},
  journal = {Current Cardiovascular Risk Reports},
  year = {2015},
  volume = {9},
  number = {2},
  doi = {10.1007/s12170-014-0430-5}
}
Kostenlos starten →